Drug Benefit News

View Sample (PDF)

Highlights on this Page

Publication Details

Subscriptions include print and electronic issues

  • Frequency: biweekly (24 issues/year)
  • Pages: 8
  • Format: Print and PDF versions
  • ISSN: 1530-3438

  • Pub Code: NDBN-11WEB

3 Easy Ways to Order

  1. Secure Shopping Cart
  2. Call 800-521-4323
  3. Print a form to fax or mail

Drug Benefit News

A hard-hitting newsletter for health plans, PBMs, pharma companies and employers. Published biweekly, it delivers timely news and in-depth accounts of cost management strategies being employed by purchasers. Coverage includes news of the continually evolving PBM landscape, soaring specialty pharmacy costs, the emerging biosimilars market, generic inflation, exclusionary formularies, new adherence strategies, pharmacy network innovation, changing reimbursement methodology and more.

Place your order through our secure shopping cart

1 copy of each issue
$671.00
5 copies of each issue — just $399 per subscription!
$1,999.00
15 copies of each issue — just $299 per subscription!
$4,499.00
50 copies of each issue — just $199 per subscription!
$9,999.00

Contact us at sales@aishealth.com for pricing on 100- and 500-subscription packages OR if you want to fill your group subscription with a combination of Drug Benefit Newsand other AIS Health newsletters.

News, Data and Business Strategies for Health Plans, Employers, PBMs and Pharma Companies

With so much at stake in the struggle to contain costs without compromising quality, it is difficult to get a clear picture of new challenges and opportunities in the pharmaceutical business, and which new strategies are working. Drug Benefit News — a biweekly newsletter focused on the issues and events with the biggest impact on pharmacy benefit management — provides news and business analysis on big-dollar topics such as:

  • The impact health insurers and PBMs could see from the Trump administration’s plan to have the FDA fast-track new drugs.
  • Whether the Biologics Price Competition and Innovation Act will survive efforts to revise the Affordable Care Act — and what its impact would be on payer strategies to accelerate biosimilars.
  • How far PBMs will go with formulary exclusions as the “generic wave” tapers off and new high-cost specialty drugs come to market.
  • The success of continuing efforts to contain the soaring cost of specialty drugs.
  • The future of pharmacy network strategies like performance-based networks and value-based benefit designs.
  • Whether the new administration will ease regulations on drug importation, and if so how that will influence pharmacy benefit designs.
  • Trends in benefit design and copay data from AIS's Rx Benefit Data.
  • The impact of changes to the star ratings program on Medicare Part D.

    … and other business issues of great concern to plans, PBMs and pharma companies.

As a subscriber to Drug Benefit News, you receive:

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • The Drug Benefit News Subscriber Library, a special website with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Bonus Insight Reports, covering key areas of concern to today’s health care executives,
    • Recent stories of interest grouped for convenient reading, and
    • Regular postings from your editor.

Stay current with rapid-fire changes in the industry. Subscribe to Drug Benefit News today!

Written By

Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for pharma publications. She also is the managing editor of AIS’s monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry.

Written For

  • Health plan managers
  • Purchasers, employers, pharmacy benefit companies
  • Managers in the pharmaceutical industry

AIS Guarantee

When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund.

Shipping Information

Electronic (PDF) versions of the newsletter are available, on the newsletter’s subscriber-only Web page, on the day of publication. Recipients should whitelist aisalert@aishealth.com to ensure delivery of the e-mail notification of new issues. Print newsletters are mailed 1st class through the U.S. Postal Service. You should receive your first issue within 5-7 business days of your order. A one-time $12 shipping and handling charge will be applied to your order.

View Sample (PDF)

Drug Benefit News

Place your order through our secure shopping cart

1 copy of each issue
$671.00
5 copies of each issue — just $399 per subscription!
$1,999.00
15 copies of each issue — just $299 per subscription!
$4,499.00
50 copies of each issue — just $199 per subscription!
$9,999.00